![Challenges in early detection of HCC Prof Simone Strasser Prof Simone Strasser](https://clinicalvalue.com/wp-content/uploads/2024/06/Prof-Simone-Strasser.png)
Early detection
![Challenges in early detection of HCC Prof Simone Strasser Prof Simone Strasser](https://clinicalvalue.com/wp-content/uploads/2024/06/Prof-Simone-Strasser.png)
![Liver cancer surveillance: what’s stopping my patients getting tested? Health Test Health Test](https://clinicalvalue.com/wp-content/uploads/2024/05/Health-Test-1280x916.jpeg)
27 May 2024
Liver cancer surveillance: what’s stopping my patients getting tested?
![Building modern hepatocellular carcinoma surveillance programmes: taking steps to address a leading cause of liver cancer death in Asia roche roche](https://clinicalvalue.com/wp-content/uploads/2023/08/roche-hcc_hero_1920x450px.jpg)
23 August 2023
Building modern hepatocellular carcinoma surveillance programmes: taking steps to address a leading cause of liver cancer death in Asia
In this whitepaper, HCC surveillance programs in Asia were analysed. The learnings from well established HCC surveillance programs, as well as the challenges in areas that…
READ MORE![Liver Cancer in Japan: Dr Shun Kaneko on HCC Screening and Surveillance Liver Cancer in Japan Dr Shun Kaneko on HCC Screening and Surveillance Liver Cancer in Japan Dr Shun Kaneko on HCC Screening and Surveillance](https://clinicalvalue.com/wp-content/uploads/2022/12/Liver-Cancer-in-Japan_-Dr-Shun-Kaneko-on-HCC-Screening-and-Surveillance.jpg)
9 December 2022
Liver Cancer in Japan: Dr Shun Kaneko on HCC Screening and Surveillance
Japan is a global leader in hepatocellular carcinoma (HCC) surveillance, with an effective programme that enables early-stage carcinomas detection. Yet unmet needs continue to affect the…
READ MORE